Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Harvard Business School
Express Scripts
Medtronic
Johnson and Johnson

Last Updated: July 1, 2022

CLINICAL TRIALS PROFILE FOR TRIGLIDE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TRIGLIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01752842 ↗ Lipid Biomarkers for Diabetic Heart Disease Completed Leducq Foundation N/A 2013-03-01 This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT01752842 ↗ Lipid Biomarkers for Diabetic Heart Disease Completed National Heart, Lung, and Blood Institute (NHLBI) N/A 2013-03-01 This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT01752842 ↗ Lipid Biomarkers for Diabetic Heart Disease Completed National Institutes of Health (NIH) N/A 2013-03-01 This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT01752842 ↗ Lipid Biomarkers for Diabetic Heart Disease Completed Washington University School of Medicine N/A 2013-03-01 This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT03829514 ↗ Fenofibrate in Type 2 Diabetes Completed Medical University of South Carolina Phase 4 2019-02-04 Diabetic complications affecting the eyes, kidneys, and nerves are difficult to arrest once in progress. Recent evidence that fenofibrate confers a robust yet unexpected benefit in diabetic retinopathy offers an important translational research opportunity. The investigator's global proteomic study will provide new clues as to how fenofibrate protects vulnerable tissues, and will spur discovery of targets for new therapeutic interventions.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TRIGLIDE

Condition Name

Condition Name for TRIGLIDE
Intervention Trials
Diabetes Complications 1
Diabetes Mellitus, Type II 1
Type II Diabetes Mellitus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TRIGLIDE
Intervention Trials
Diabetes Mellitus, Type 2 2
Diabetes Mellitus 2
Heart Diseases 1
Diabetes Complications 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TRIGLIDE

Trials by Country

Trials by Country for TRIGLIDE
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for TRIGLIDE
Location Trials
South Carolina 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TRIGLIDE

Clinical Trial Phase

Clinical Trial Phase for TRIGLIDE
Clinical Trial Phase Trials
Phase 4 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TRIGLIDE
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TRIGLIDE

Sponsor Name

Sponsor Name for TRIGLIDE
Sponsor Trials
Leducq Foundation 1
National Heart, Lung, and Blood Institute (NHLBI) 1
National Institutes of Health (NIH) 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TRIGLIDE
Sponsor Trials
Other 3
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Medtronic
Colorcon
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.